Ruxolitinib changes the natural course of myelofibrosis and its transplant outcome

Chul Won Jung1

  • 1Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

Blood Research
|April 17, 2013
PubMed
Abstract

No abstract available in PubMed .